Arş. Gör. AYŞEGÜL YILDIZ SAZLIKOĞLU

Yayın Ağı

Makaleler 20

1. Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs

Similon M. v. M., Paasche C., Krol F., Lerer B., Goodwin G. M., Berk M., et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY , cilt.60, ss.91-99, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

Reininghaus E. Z., Manchia M., Dalkner N., Bonkat N., Squassina A., Hodl I., et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY , cilt.54, ss.90-99, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Association Between Anterior Cingulate Cortex Neurochemical Profile and Clinical Remission After Electroconvulsive Treatment in Major Depressive Disorder A Longitudinal H-1 Magnetic Resonance Spectroscopy Study

Ermiş Ç., Aydin B., Küçükgüçlü S., Yurt A., Renshaw P. F., Yıldız A.

JOURNAL OF ECT , cilt.37, sa.4, ss.263-269, 2021 (SCI-Expanded, SSCI, Scopus)

4. DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis-A narrative review from the ECNP bipolar disorders network

Kessing L. V., Gonzalez-Pinto A., Fagiolini A., Bechdolf A., Reif A., YILDIZ A., et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY , cilt.47, ss.54-61, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action

Manchia M., Vieta E., Smeland O. B., Altimus C., Bechdolf A., Bellivier F., et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY , cilt.36, ss.121-136, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Tamoxifen for bipolar disorder: Systematic review and meta-analysis

Palacios J., YILDIZ A., Young A. H., Taylor M. J.

JOURNAL OF PSYCHOPHARMACOLOGY , cilt.33, sa.2, ss.177-184, 2019 (SCI-Expanded, Scopus)

7. Trait-related alterations of N-acetylaspartate in euthymic bipolar patients: A longitudinal proton magnetic resonance spectroscopy study

Aydin B., Yurt A., Gokmen N., Renshaw P., Olson D., Yıldız A.

JOURNAL OF AFFECTIVE DISORDERS , cilt.206, ss.315-320, 2016 (SCI-Expanded, SSCI, Scopus)

8. Antimanic Treatment with Tamoxifen Affects Brain Chemistry: A Double-Blind, Placebo-Controlled Proton Magnetic Resonance Spectroscopy Study

Yıldız A., Aydin B., Gökmen N., Yurt A., Cohen B., Keskinoğlu P., et al.

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging , cilt.1, sa.2, ss.125-131, 2016 (Scopus)

9. Olanzapine and quetiapine use during breastfeeding

Aydin B., Nayir T., ŞAHİN S., YILDIZ A.

Journal of Clinical Psychopharmacology , cilt.35, sa.2, ss.206-208, 2015 (SCI-Expanded, Scopus)

10. Critical Issues on the Use of Network Meta-analysis in Psychiatry

YILDIZ A., Vieta E., Correll C. U., Nikodem M., Baldessarini R. J.

HARVARD REVIEW OF PSYCHIATRY , cilt.22, sa.6, ss.367-372, 2014 (SCI-Expanded, SSCI, Scopus)

11. Unexplored Areas of Psychotherapy in Bipolar Disorder

Popovic D., YILDIZ A., Murphy P., Colom F.

HARVARD REVIEW OF PSYCHIATRY , cilt.22, sa.6, ss.373-378, 2014 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

12. Introduction

Ongur D., YILDIZ A.

HARVARD REVIEW OF PSYCHIATRY , cilt.22, sa.6, ss.325, 2014 (SCI-Expanded, SSCI, Scopus)

13. The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

Pacchiarotti I., Bond D. J., Baldessarini R. J., Nolen W. A., Grunze H., Licht R. W., et al.

AMERICAN JOURNAL OF PSYCHIATRY , cilt.170, sa.11, ss.1249-1262, 2013 (SCI-Expanded, SSCI, Scopus)

14. Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients

Baldessarini R. J., Tondo L., Vazquez G. H., Undurraga J., Bolzani L., Yildiz A., et al.

WORLD PSYCHIATRY , cilt.11, sa.1, ss.40-46, 2012 (SCI-Expanded, SSCI, Scopus)

15. Multisite international collaborative clinical trials in mania

Vazquez G., Baldessarini R. J., Yildiz A., Tamayo J., Tondo L., Salvatore P.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY , cilt.14, sa.8, ss.1013-1016, 2011 (SCI-Expanded, Scopus)

16. Factors modifying drug and placebo responses in randomized trials for bipolar mania

YILDIZ A., Vieta E., Tohen M., Baldessarini R. J.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY , cilt.14, sa.7, ss.863-875, 2011 (SCI-Expanded, Scopus)

17. In vivo proton magnetic resonance spectroscopic examination of benzodiazepine action in humans

Yıldız A., Gokmen N., Küçükgüçlü S., Yurt A., Olson D., Rouse E. D., et al.

PSYCHIATRY RESEARCH-NEUROIMAGING , cilt.184, sa.3, ss.162-170, 2010 (SCI-Expanded, Scopus)

18. A cross-over, post-electroconvulsive therapy comparison of clinical recovery from rocuronium versus succinylcholine

Turkkal D. C., Gokmen N., YILDIZ A., İYİLİKÇİ KARAOĞLAN L., GÖKEL E., Sagduyu K., et al.

JOURNAL OF CLINICAL ANESTHESIA , cilt.20, sa.8, ss.589-593, 2008 (SCI-Expanded, Scopus)

19. Olanzapine attenuates brain damage after focal cerebral ischemia in vivo

Yulug B., Yildiz A., Hudaoglu O., Kilic E., Cam E., Schaebitz W. R.

BRAIN RESEARCH BULLETIN , cilt.71, ss.296-300, 2006 (SCI-Expanded, Scopus)

20. Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study

Sagduyu K., Dokucu M. E., Eddy B. A., Craigen G., Baldassano C. F., YILDIZ A.

NUTRITION JOURNAL , cilt.4, 2005 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 3

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

848

H-İndeks (WoS)

Atıf (Scopus)

923

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (Sobiad)

H-İndeks (Sobiad)

Atıf (Diğer Toplam)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları